# Arcadia Biosciences, Inc.: filings

RKDA · Nasdaq · CIK 1469443 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rkda.md) · [Financials](/companies/rkda/financials.md) · [Filings](/companies/rkda/filings.md) · [Insiders](/companies/rkda/insiders.md)

## Reports and events: 223 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 159, 8-K 138, 3 36, 10-Q 35, CORRESP 22, 424B3 16, UPLOAD 16, DEF 14A 14, EFFECT 14, SC 13G/A 14, 10-K 11, S-8 11, SC 13G 11, DEFA14A 10, S-3 8, D 7, 425 6, S-1 6, 10-K/A 5, 424B5 5, 4/A 5, 8-K/A 5, PRE 14A 5, S-1/A 5, 3/A 3, SC 13D/A 3, SCHEDULE 13G 3, ARS 2, CERTNAS 2, DRSLTR 2, S-3/A 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, 8-A12B/A 1, 8-A12G 1, CT ORDER 1, DRS 1, DRS/A 1, RW 1, S-4 1, S-4/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 15:01 ET | [8-K](/filings/0001193125-26-391780.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-391780 |
| 2026-09-04 | 16:05 ET | [8-K](/filings/0001193125-26-383642.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-383642 |
| 2026-08-13 | 16:13 ET | [10-Q](/filings/0001193125-26-349205.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349205 |
| 2026-08-13 | 16:10 ET | [8-K](/filings/0001193125-26-349180.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349180 |
| 2026-08-10 | 16:17 ET | [DEF 14A](/filings/0001193125-26-342437.md) | Proxy statement, period 2026-08-10 | 0001193125-26-342437 |
| 2026-08-10 | 18:49 ET | [8-K](/filings/0001193125-26-340664.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-340664 |
| 2026-07-02 | 16:21 ET | [8-K](/filings/0001193125-26-294619.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-294619 |
| 2026-06-15 | 11:31 ET | [8-K](/filings/0001193125-26-270560.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-270560 |
| 2026-05-14 | 16:07 ET | [10-Q](/filings/0001193125-26-223990.md) | Quarterly report, period 2026-03-31 | 0001193125-26-223990 |
| 2026-05-14 | 16:06 ET | [8-K](/filings/0001193125-26-223985.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-223985 |
| 2026-04-30 | 16:14 ET | [10-K/A](/filings/0001193125-26-197315.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197315 |
| 2026-04-03 | 15:31 ET | [8-K](/filings/0001193125-26-142030.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-142030 |
| 2026-03-26 | 16:09 ET | [10-K](/filings/0001193125-26-126238.md) | Annual report, period 2025-12-31 | 0001193125-26-126238 |
| 2026-03-26 | 16:07 ET | [8-K](/filings/0001193125-26-126220.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126220 |
| 2026-02-06 | 16:03 ET | [8-K](/filings/0001193125-26-041144.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-041144 |
| 2026-01-14 | 20:07 ET | [8-K](/filings/0001193125-26-012028.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-012028 |
| 2025-12-29 | 16:30 ET | [8-K](/filings/0001193125-25-335410.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-335410 |
| 2025-12-23 | 16:30 ET | [8-K](/filings/0001193125-25-331009.md) | 5.07 Shareholder vote results | 0001193125-25-331009 |
| 2025-11-19 | 16:30 ET | [DEF 14A](/filings/0001193125-25-288164.md) | Proxy statement, period 2025-12-19 | 0001193125-25-288164 |
| 2025-11-07 | 16:15 ET | [10-Q](/filings/0001193125-25-272375.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272375 |
| 2025-11-07 | 16:12 ET | [8-K](/filings/0001193125-25-272368.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-272368 |
| 2025-10-24 | 15:13 ET | [8-K](/filings/0001193125-25-249854.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-249854 |
| 2025-08-29 | 17:04 ET | [8-K](/filings/0000950170-25-112267.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-112267 |
| 2025-08-14 | 17:02 ET | [10-Q](/filings/0000950170-25-109040.md) | Quarterly report, period 2025-06-30 | 0000950170-25-109040 |
| 2025-08-14 | 16:33 ET | [8-K](/filings/0000950170-25-108983.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108983 |
| 2025-05-16 | 17:21 ET | [8-K](/filings/0000950170-25-073711.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-073711 |
| 2025-05-08 | 08:07 ET | [10-Q](/filings/0000950170-25-066425.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066425 |
| 2025-05-08 | 08:05 ET | [8-K](/filings/0000950170-25-066420.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066420 |
| 2025-05-02 | 17:01 ET | [8-K](/filings/0000950170-25-062913.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-062913 |
| 2025-04-30 | 16:08 ET | [10-K/A](/filings/0000950170-25-061044.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-061044 |
| 2025-04-03 | 16:15 ET | [8-K](/filings/0000950170-25-050406.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-050406 |
| 2025-03-25 | 16:44 ET | [10-K](/filings/0000950170-25-044487.md) | Annual report, period 2024-12-31 | 0000950170-25-044487 |
| 2025-03-20 | 16:06 ET | [8-K](/filings/0000950170-25-042647.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042647 |
| 2024-12-11 | 17:09 ET | [8-K](/filings/0000950170-24-135447.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-135447 |
| 2024-12-06 | 20:53 ET | [8-K](/filings/0000950170-24-133817.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-133817 |
| 2024-11-12 | 17:00 ET | [10-Q](/filings/0000950170-24-125613.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125613 |
| 2024-11-12 | 16:10 ET | [8-K](/filings/0000950170-24-125393.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125393 |
| 2024-08-23 | 11:56 ET | [8-K/A](/filings/0000950170-24-100065.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-100065 |
| 2024-08-13 | 17:16 ET | [10-Q](/filings/0000950170-24-096439.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096439 |
| 2024-08-13 | 16:11 ET | [8-K](/filings/0000950170-24-096215.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096215 |
| 2024-08-07 | 12:07 ET | [8-K](/filings/0000950170-24-092432.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-092432 |
| 2024-07-08 | 16:11 ET | [8-K](/filings/0000950170-24-082092.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-082092 |
| 2024-07-01 | 16:10 ET | [8-K](/filings/0000950170-24-079602.md) | 5.07 Shareholder vote results | 0000950170-24-079602 |
| 2024-05-20 | 16:33 ET | [8-K](/filings/0000950170-24-062449.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-24-062449 |
| 2024-05-17 | 15:15 ET | [8-K](/filings/0000950170-24-061526.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-24-061526 |
| 2024-05-16 | 14:13 ET | [DEF 14A](/filings/0000950170-24-060967.md) | Proxy statement, period 2024-05-16 | 0000950170-24-060967 |
| 2024-05-13 | 15:31 ET | [10-Q](/filings/0000950170-24-058563.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058563 |
| 2024-05-09 | 16:08 ET | [8-K](/filings/0000950170-24-056928.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056928 |
| 2024-04-29 | 14:07 ET | [10-K/A](/filings/0000950170-24-049710.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-049710 |
| 2024-03-28 | 17:20 ET | [10-K](/filings/0000950170-24-038176.md) | Annual report, period 2023-12-31 | 0000950170-24-038176 |

Page 1 of 5. [Older](/companies/rkda/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.